Daniel Myatt

Dr. Daniel Myatt


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Chirality
Verified
Journal Article
Closed access
PDF file
TJTamás Jávorfi
Tamás Jávorfi
RHRohanah Hussain
Rohanah Hussain
DMDaniel Myatt
Daniel Myatt
GSGiuliano Siligardi
Giuliano Siligardi

23 December 2009 in Macromolecular Bioscience
Verified
Journal Article
Closed access
PDF file
IHIan W. Hamley
Ian W. Hamley
VCValeria Castelletto
Valeria Castelletto
CMClaire Moulton
Claire Moulton
DMDaniel Myatt
Daniel Myatt
GSGiuliano Siligardi
Giuliano Siligardi
DDDganit Danino
Dganit Danino

30 April 2015 in Journal of Synchrotron Radiation
Verified
Journal Article
Open access
PDF file
RHRohanah Hussain
Rohanah Hussain
KBKristian Benning
Kristian Benning
DMDaniel Myatt
Daniel Myatt
TJTamas Javorfi
Tamas Javorfi
Edoardo LongoEdoardo Longo
Edoardo Longo
GSGiuliano Siligardi
Giuliano Siligardi
In the paper by Hussainet al.[(2015),J. Synchrotron Rad.22, 465–468], Daniel Myatt is missing from the list of authors. The complete list of authors should be Rohanah Hussain, Kristian Benning, Daniel Myatt, Tamas Javorfi, Edoardo Longo, Timothy R. Rudd, Bill Pulford and Giuliano Siligardi.

1 February 2007 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
LLLu-Yun Lian
Lu-Yun Lian
DMDaniel Myatt
Daniel Myatt
AKAshraf Kitmitto
Ashraf Kitmitto

1 January 2023 in Biology Methods and Protocols
Verified
Journal Article
Open access
PDF file
DMDaniel Myatt
Daniel Myatt
LWLewis Wharram
Lewis Wharram
CGCharlotte Graham
Charlotte Graham
JLJohn Liddell
John Liddell
HBHarvey Branton
Harvey Branton
RSRobin J Shattock
Robin J Shattock
The current SARS-Covid-2 (SARS-CoV-2) pandemic has led to an acceleration of messenger ribonucleic acid (mRNA) vaccine technology. The development of production processes for these large mRNA molecules, especially self-amplifying mRNA (saRNA), has required concomitant development of analytical characterization techniques. Characterizing the purity, shape and structure of these biomolecules is key to their successful performance as drug products. This article describes the biophysical characterization of the Imperial College London Self-amplifying viral RNA vaccine (IMP-1) developed for SARS-CoV-2. A variety of analytical techniques have been used to characterize the IMP-1 RNA molecule. In this article, we use ultraviolet spectroscopy, dynamic light scattering, size-exclusion chromatography small-angle X-ray scattering and circular dichroism to determine key biophysical attributes of IMP-1. Each technique provides important information about the concentration, size, shape, structure and purity of the molecule.

1 January 2010 in Chirality
Verified
Journal Article
Closed access
PDF file
DMDaniel Myatt
Daniel Myatt
LJLouise Johnson
Louise Johnson
SBSonja Baumli
Sonja Baumli
GSGiuliano Siligardi
Giuliano Siligardi